Skip to content
Search

Latest Stories

Period matters! Women pharmacists share their experiences with menstrual symptoms

Period matters! Women pharmacists share their experiences with menstrual symptoms
Period Leave

PDA NAWP Network highlights the impact of periods on women and encourages employers to create a more period-friendly workplace

“Growing up, I was always told not to talk about my period because it’s embarrassing and might make the people around me feel uncomfortable. I used to ensure that I hide my period pad and felt so ashamed for having a period,” said Ayah Abbass, Clinical Pharmacist and President of the PDA NAWP Network


Ayah is among the eight women pharmacists who have shared their personal experiences with period symptoms as part of a PDA campaign, which aims to highlight the impact of periods on women at work and in day-to-day life.

The latest NAWP Spotlight, ‘Period Matters’ aims to raise awareness of this issue and encourage employers to support people who menstruate, helping them to thrive at work.

Explaining this year’s Spotlight, the PDA NAWP Network noted, “Although so many employees menstruate while at work, there is still a lack of empathy and support that needs addressing.”

The PDA cited a report by the Chartered Institute of Personnel and Development, which found that nearly four in five women have experienced menstruation symptoms, and over two-thirds of those with symptoms have experienced a negative impact at work.

However, only 12 per cent of organisations provide support for menstruation and menstrual health.

Ayah shared that as she got older, her period pain became more intense.

“I also started to experience symptoms that might not be a common symptom of periods but I knew it was associated with my period,” she said, emphasising the importance of sharing personal experiences to raise awareness and promote a better understanding of menstrual health.

She recounted a day at the community pharmacy when she experienced intense period pain, making it difficult for her to stand.

“I had to whisper to my staff that I was on my period! My staff were so supportive and I had the chance to use a hot water bottle and rest.”

“This little action made a huge difference to me! This made me realise, why don’t we talk about our suffering to help make our period journey easier?”

She stressed the importance of discussing periods openly and feeling safe to do so without embarrassment.

The PDA NAWP Network President also strongly encourages employers to provide period products for their staff, noting that unexpected periods can occur, especially in unfamiliar surroundings.

Dimitra Gkiorou, a mental health pharmacist, shared that as a woman working in a busy environment, menstruation significantly affects her professional performance and daily life.

“The physical discomfort, like cramps and fatigue, often presents obstacles to maintaining topnotch productivity while catering to patients' needs. Moreover, the emotional fluctuations inherent in this cycle can influence my mood, interactions, and decision-making during pivotal moments at work,” she said.

Una O’Farrell, PDA National Officer for Northern Ireland, noted that Spain, Japan, Taiwan, and Indonesia have policies allowing women to take paid leaves for painful period symptoms.

However, she pointed out that in Britain and Ireland, there are no concessions for women’s health – whether it is menopause, periods, or other limiting conditions

She underscored that implementing such measures would be “the starting point for making the workplace a nurturing and inclusive space for women to do their jobs.”

However, she emphasised that the finer details of such a bill need thorough scrutiny to ensure that everyone experiencing menstruation or related symptoms can exercise their legal rights without compromising their dignity.

The PDA encourages pharmacists to download this year’s NAWP Spotlight, ‘Period Matters’ and share it with their colleagues and employers.

NAWP Spotlights, first introduced in October 2023 with the release of ‘Menopause Matters’ to mark World Menopause Day, provide a platform for women in pharmacy to share their personal experiences with important issues and their impact at work.

By highlighting the day-to-day experiences of women, the network hopes to normalise these topics and support women by showing them they are not alone.

More For You

How to leverage data to drive pharmacy growth

Adele Curran, chief operating officer at Real World Analytics (RWA) Pharmacy.

Pharmacy challenges: How data can help spot the ‘elephant in the room’

Adopting new technologies is vital for moving pharmacy forward — but are you fully harnessing the data these tools generate?

“Being able to utilise, manage, and interpret the data these technologies provide can help add more value to your business,” said Adele Curran, chief operating officer at Real World Analytics (RWA) Pharmacy, while speaking at the recent Pharmacy Business Conference.

Keep ReadingShow less
Branded OTC products can boost pharmacy revenue and promote self-care, says PAGB CEO

Michelle Riddalls

How branded OTC products can help struggling community pharmacies - PAGB chief explains

Branded over-the-counter (OTC) products could play a vital role in promoting self-care and supporting the sustainability of community pharmacies, said Michelle Riddalls, CEO of PAGB – the consumer healthcare association – during the recent Pharmacy Business Conference.

Riddalls emphasised that OTC medicines not only enable consumers to better manage their health through self-care but also offer pharmacies an opportunity to increase revenue, particularly during a time of mounting financial pressure.

Keep ReadingShow less
How Peptides Are Transforming Modern Drug Development

Modern Drug Development

How Peptides Are Transforming Modern Drug Development

The pharmaceutical industry is rapidly evolving, embracing new technologies and methodologies. Peptides are emerging as a crucial component in this transformation, offering innovative solutions to drug development. This shift is not only reshaping how drugs are discovered but also enhancing their efficacy and safety.

In recent years, the pharmaceutical landscape has undergone significant changes, driven by advancements in technology and scientific understanding. One of the most promising areas of innovation is the use of peptides in drug development. These short chains of amino acids have proven to be versatile tools, capable of targeting specific cells or molecules with high precision. In this context, certain bpc 157 peptide research peptides have been highlighted for their potential applications in various therapeutic areas, showcasing the promise that peptides hold for modern pharmaceutical studies.

Keep ReadingShow less
Off-patent medicines could save NHS millions—but only if UK remains attractive to suppliers - BGMA

BGMA chief executive Mark Samuels urges government to back off-patent medicines ahead of Life Sciences Plan release.

UK risks losing millions in NHS savings without stronger support for generics - BGMA

The British Generic Manufacturers Association (BGMA) has called on the government to create a more supportive environment for the generics and biosimilars sector, warning that the UK risks missing out on significant NHS savings arising from new off-patent medicines.

According to the BGMA, 31 medicines are due to lose patent protection between January and June 2025, with a further 28 set to follow in the second half of the year.

Keep ReadingShow less
Support for generic medicines manufacturers key to affordable healthcare- Teva UK director

Teva UK sounds alarm on accelerating consolidation of critical generic medicines

Photo credit: gettyimages

Exclusive: Teva UK calls for inclusion of generic manufacturers in policy talks

A healthy and vibrant generics marketplace supports not only patients but also contributes billions of pounds in savings to the drugs bill. However, growing pressures on generic medicine manufacturers could threaten this vital part of the healthcare ecosystem, warns Ryan Ruscoe, senior director of generics and OTC at Teva UK.

Speaking exclusively to Pharmacy Business, Ruscoe stressed the urgent need to address supply chain vulnerabilities, particularly for critical generic medicines.

Keep ReadingShow less